Н Нуриллаева

5 та иш

Tashkent Medical Academy

1. Clinical and diagnostic significance of plasminogen activator inhibitor type 1 in the early development of coronary heart disease

   Н Нуриллаева, Н А Хасанова, Muborakkhon Zokirova

   МақолаApelin-related biomedical researchScience and Innovations in Medicine20230 иқтибос

   ABIABI:AkademIndex/openalex/2023.article.004836

2. Comparative analysis of cardiometabolic parameters in patients with coronary heart disease with and without non-alcoholic fatty liver disease

   D. B. Yusupalieva, Р Алиева, Ulugbek Nizamov +4

   МақолаLiver Disease Diagnosis and TreatmentExploration of Cardiology20250 иқтибос

   ABIABI:AkademIndex/openalex/2025.article.005824

3. Assessment of cardiovascular complications during chemotherapy in patients with acute lymphoblastic leukemia

   Muborakkhon Zokirova, Abdurakhman Kayumov, Н Нуриллаева

   МақолаChemotherapy-induced cardiotoxicity and mitigationAtherosclerosis20250 иқтибос

   ABIABI:AkademIndex/openalex/2025.article.007915

4. Role of the plasma level of plasminogen activator inhibitor type-1 (PAI-1) and genetic polymorphism of <i>PAI-1</i> gene in patients with ischemic heart disease in Uzbek population

   Наргиза Абдумухтаровна Кадирова, Н Нуриллаева, Victoria B. Petrova +2

   МақолаProtease and Inhibitor MechanismsScience and Innovations in Medicine20250 иқтибос

   ABIABI:AkademIndex/openalex/2025.article.009397

5. Early biomarkers of endothelial dysfunction: clinical implications for the diagnosis and management of cardiovascular disease

   Н Нуриллаева, Nigora Srojidinova, Munisa Makhkamova +1

   МақолаNitric Oxide and Endothelin EffectsCardiology of Uzbekistan.20250 иқтибос

   ABIABI:AkademIndex/openalex/2025.article.009547